These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 24650768)

  • 1. Bioresorbable vascular scaffolds: is imaging everything?
    Stone GW
    EuroIntervention; 2014 Mar; 9(11):1255-7. PubMed ID: 24650768
    [No Abstract]   [Full Text] [Related]  

  • 2. Provisional T-stenting with bioresorbable vascular scaffolds in vivo: insights from optical frequency domain imaging.
    Naganuma T; Ishiguro H; Takagi K; Fujino Y; Mitomo S; Nakamura S; Nakamura S; Colombo A
    JACC Cardiovasc Interv; 2015 Apr; 8(4):635-7. PubMed ID: 25819186
    [No Abstract]   [Full Text] [Related]  

  • 3. From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?
    Serruys PW; Garcia-Garcia HM; Onuma Y
    Eur Heart J; 2012 Jan; 33(1):16-25b. PubMed ID: 22041548
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioresorbable scaffolding after drug-coated balloons: a new chapter of the "leave nothing behind" saga.
    Cortese B; Sebik R; Seregni R; Silva PL
    Int J Cardiol; 2014 May; 173(3):e67-9. PubMed ID: 24704408
    [No Abstract]   [Full Text] [Related]  

  • 5. Vascular restoration therapy: the fourth revolution in interventional cardiology and the ultimate "rosy" prophecy.
    Wykrzykowska JJ; Onuma Y; Serruys PW
    EuroIntervention; 2009 Dec; 5 Suppl F():F7-8. PubMed ID: 22100680
    [No Abstract]   [Full Text] [Related]  

  • 6. Design principles and performance of bioresorbable polymeric vascular scaffolds.
    Oberhauser JP; Hossainy S; Rapoza RJ
    EuroIntervention; 2009 Dec; 5 Suppl F():F15-22. PubMed ID: 22100671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The buddy balloon technique to release a sticky ABSORB bioresorbable vascular scaffold balloon post-scaffolding.
    Yew KL
    Int J Cardiol; 2016 Mar; 207():1-2. PubMed ID: 26784563
    [No Abstract]   [Full Text] [Related]  

  • 8. Five-year follow-up of the ABSORB bioresorbable everolimus-eluting vascular scaffold system: multimodality imaging assessment.
    García-García HM; Schultz C; Duckers E; Regar E; Ligthart J; Serruys PW; van Geuns RJ
    EuroIntervention; 2013 Feb; 8(10):1126-7. PubMed ID: 23014900
    [No Abstract]   [Full Text] [Related]  

  • 9. [The bioresorbable coronary scaffold].
    Hassell ME; van de Hoef TP; Damman P; Delewi R; Serruys PW; Piek JJ
    Ned Tijdschr Geneeskd; 2012; 156(36):A4994. PubMed ID: 22951133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The absorb bioresorbable vascular scaffold in coronary bifurcations: insights from bench testing.
    Džavík V; Colombo A
    JACC Cardiovasc Interv; 2014 Jan; 7(1):81-8. PubMed ID: 24332424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A.R.T.: concept of a bioresorbable stent without drug elution.
    Lafont A; Durand E
    EuroIntervention; 2009 Dec; 5 Suppl F():F83-7. PubMed ID: 22100683
    [No Abstract]   [Full Text] [Related]  

  • 12. Engineering a bioresorbable stent: REVA programme update.
    Pollman MJ
    EuroIntervention; 2009 Dec; 5 Suppl F():F54-7. PubMed ID: 22100677
    [No Abstract]   [Full Text] [Related]  

  • 13. Bioresorbable scaffolds: talking about a new interventional revolution [corrected].
    Hassell ME; Grundeken MJ; Delewi R; Wykrzykowska JJ; Piek JJ
    Minerva Cardioangiol; 2013 Apr; 61(2):165-79. PubMed ID: 23492600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization?
    Onuma Y; Serruys PW
    Circulation; 2011 Feb; 123(7):779-97. PubMed ID: 21343594
    [No Abstract]   [Full Text] [Related]  

  • 15. Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months.
    Serruys PW; Onuma Y; Garcia-Garcia HM; Muramatsu T; van Geuns RJ; de Bruyne B; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Hebert KM; Rapoza R; Ormiston JA
    EuroIntervention; 2014 Mar; 9(11):1271-84. PubMed ID: 24291783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The bioresorbable coronary stent: a revolution].
    Koegler F; De Benedetti E
    Rev Med Suisse; 2013 Apr; 9(381):775-8. PubMed ID: 23659156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which child catheter should we choose to deliver a bulky bioresorbable vascular scaffold?
    Naganuma T; Ishiguro H; Panoulas VF; Fujino Y; Mitomo S; Kawamoto H; Nakamura S; Colombo A
    Int J Cardiol; 2016 Jan; 203():781-2. PubMed ID: 26595782
    [No Abstract]   [Full Text] [Related]  

  • 18. Elixir Medical's bioresorbable drug eluting stent (BDES) programme: an overview.
    Yan J; Bhat VD
    EuroIntervention; 2009 Dec; 5 Suppl F():F80-2. PubMed ID: 22100682
    [No Abstract]   [Full Text] [Related]  

  • 19. Late loss in a disappearing frame of reference: is it still applicable to fully absorbable scaffolds?
    Bangalore S; Mauri L
    EuroIntervention; 2009 Dec; 5 Suppl F():F43-8. PubMed ID: 22100675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OrbusNeich fully absorbable coronary stent platform incorporating dual partitioned coatings.
    Cottone RJ; Thatcher GL; Parker SP; Hanks L; Kujawa DA; Rowland SM; Costa M; Schwartz RS; Onuma Y
    EuroIntervention; 2009 Dec; 5 Suppl F():F65-71. PubMed ID: 22100679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.